caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1477714319

Anthony RossiM.D.

DermatologyNew York, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Anthony Rossi's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 6 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
HOLLMANN, TRAVIS56234
Melissa Pulitzer
Pathology · New York, NY
53188
Allan Halpern
Dermatology · New York, NY
1167
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES1742,587
Klaus Busam
Pathology · New York, NY
43147
Melissa Pulitzer
Pathology · New York, NY
1956
HOLLMANN, TRAVIS1846
Quest Diagnostics Incorporated
Clinical Laboratory · Clifton, NJ
1767
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
1148
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,175
Unique beneficiaries
—
Total services
1,741
Distinct HCPCS
23
Medicare payment
$196K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 960 Dermatology providers in NY — above median (cohort median 1,575).
PRESCRIBING · PART D · 2024
Total Rx claims
147
Beneficiaries
—
Total drug cost
$3K
Distinct drugs
4
Brand share
0.0%
Top prescribed drugs
Mupirocin89 claims
Cefadroxil29 claims
Fluorouracil18 claims
Silver Sulfadiazine11 claims
QUALITY · MIPS · 2024
Final MIPS score
88.8
Quality
84.7
Cost
66.9
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.58%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$215K
Payment records
163
By payment type
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$157K
Consulting Fee$29K
Travel and Lodging$22K
Food and Beverage$4K
Honoraria$3K